Skip to main content
Premium Trial:

Request an Annual Quote

BioSolutions, Bioquote Reach Distribution Deal for UK, Ireland

NEW YORK (GenomeWeb News) – Claremont BioSolutions today announced a distribution deal with Bioquote covering the UK and Ireland.

The deal is for Claremont's products for sample preparation, DNA isolation, and protein purification and extends the Upland, Calif.-based company's reach into Europe. The first product to be marketed will be the company's Omnilyse lysis kits and PureLyse extraction kits.

Claremont develops, manufactures, and markets cell lysis, DNA extraction, and His-tagged protein purification kits and columns. Bioquote, headquartered in York, UK, distributes life science products throughout Europe.

Financial and other terms of the deal were not disclosed.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.